BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3684175)

  • 1. Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide.
    Bezwoda WR; Mansoor N; Dansey R
    Oncology; 1987; 44(6):345-9. PubMed ID: 3684175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
    Harris AL
    Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC; Okubo T; Sun XZ; Chen S
    Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between tumour aromatase activity, tumour characteristics and response to therapy.
    Miller WR; Anderson TJ; Jack WJ
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1055-9. PubMed ID: 2285581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
    Santen RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging role of aromatase inhibitors in the treatment of breast cancer.
    Harvey HA
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamental research leading to improved endocrine therapy for breast cancer.
    Miller WR
    J Steroid Biochem; 1987; 27(1-3):477-85. PubMed ID: 3320538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aromatase inhibitor].
    Stein M
    Med Monatsschr Pharm; 1993 Mar; 16(3):66-7. PubMed ID: 8464387
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K; Jänicke F
    Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM; Santen RJ
    Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy.
    Lawrence BV; Lipton A; Harvey HA; Santen RJ; Wells SA; Cox CE; White DS; Smart EK
    Cancer; 1980 Feb; 45(4):786-91. PubMed ID: 7357495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
    Holdaway IM
    Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of aromatase activity in human breast cancer.
    Miller WR; Hawkins RA; Forrest AP
    Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ; Daly MJ; Smith HJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.